TIBET PHARMA(SH:600211) Shang Hai Zheng Quan Bao·2026-02-05 18:12Group 1 - The company plans to provide a guarantee of up to RMB 120 million for its subsidiary Accuredit Therapeutics Limited to support the operational and R&D funding needs of its wholly-owned subsidiary, Ruizheng Suzhou [1][2] - The guarantee is deemed necessary and reasonable as it enhances the flexibility of fund utilization and supports the stable operation and long-term development of the subsidiaries [2][3] - The board of directors approved the guarantee proposal with unanimous support, indicating confidence in the operational and financial stability of the subsidiaries [2][3] Group 2 - As of the announcement date, the total amount of external guarantees provided by the company and its subsidiaries is RMB 800 million, which accounts for 20.24% of the company's latest audited net assets [4] - The actual balance of external guarantees is RMB 780 million and USD 1.57 million, representing 20.01% of the company's latest audited net assets [4] - The company has not provided guarantees to its controlling shareholders or related parties, and there are no overdue guarantees [4] Group 3 - The company will hold its first extraordinary shareholders' meeting of 2026 on February 25, 2026, with both on-site and online voting options available [5][6] - The meeting will take place at the company's office in Chengdu, Sichuan Province, starting at 14:30 [6] - Shareholders can register for the meeting from February 12, 2026, and are encouraged to participate through the Shanghai Stock Exchange's online voting system [12][15]